Crossmark

Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment

Crossref DOI link: https://doi.org/10.1007/s00280-016-3068-9

Published Online: 2016-06-10

Published Print: 2016-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bridoux, Frank

Chen, Nianhang

Moreau, Stephane

Arnulf, Bertrand

Moumas, Eric

Abraham, Julie

Desport, Estelle

Jaccard, Arnaud

Fermand, Jean Paul
Funding

Funding for this research was provided by:

Celgene
License Information

License valid from 2016-06-10